MX2019007972A - Inhibidores de il-8 para usarse en el tratamiento de algunos trastornos urologicos. - Google Patents
Inhibidores de il-8 para usarse en el tratamiento de algunos trastornos urologicos.Info
- Publication number
- MX2019007972A MX2019007972A MX2019007972A MX2019007972A MX2019007972A MX 2019007972 A MX2019007972 A MX 2019007972A MX 2019007972 A MX2019007972 A MX 2019007972A MX 2019007972 A MX2019007972 A MX 2019007972A MX 2019007972 A MX2019007972 A MX 2019007972A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- inihibitors
- urological disorders
- chronic
- cpps
- Prior art date
Links
- 208000014001 urinary system disease Diseases 0.000 title 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 1
- 108090001007 Interleukin-8 Proteins 0.000 abstract 1
- 208000000450 Pelvic Pain Diseases 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 208000013507 chronic prostatitis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013256 coordination polymer Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 201000007094 prostatitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17150176.0A EP3342407A1 (en) | 2017-01-03 | 2017-01-03 | Il-8 inihibitors for use in the treatment of some urological disorders |
| PCT/EP2018/050009 WO2018127469A1 (en) | 2017-01-03 | 2018-01-02 | Il-8 inihibitors for use in the treatment of some urological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019007972A true MX2019007972A (es) | 2019-09-09 |
Family
ID=57758480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019007972A MX2019007972A (es) | 2017-01-03 | 2018-01-02 | Inhibidores de il-8 para usarse en el tratamiento de algunos trastornos urologicos. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20190336484A1 (https=) |
| EP (2) | EP3342407A1 (https=) |
| JP (1) | JP2020503267A (https=) |
| KR (1) | KR20190102177A (https=) |
| CN (1) | CN109937037A (https=) |
| AU (1) | AU2018206134A1 (https=) |
| BR (1) | BR112019009588A2 (https=) |
| CA (1) | CA3046531A1 (https=) |
| EA (1) | EA201991357A1 (https=) |
| IL (1) | IL267577A (https=) |
| MA (1) | MA47199A (https=) |
| MX (1) | MX2019007972A (https=) |
| WO (1) | WO2018127469A1 (https=) |
| ZA (1) | ZA201902427B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3868368A1 (en) * | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Cxcl8 (interleukin-8) activity inhibitor and corticosteroid combination and pharmaceutical composition and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1212051A4 (en) * | 1999-08-27 | 2004-03-31 | Merck & Co Inc | METHOD FOR TREATING OR PREVENTING CHEMICAL PROSTATITIS OR CHRONIC POOL PAIN |
| PL1776336T3 (pl) | 2004-03-23 | 2010-06-30 | Dompe Farm Spa | Pochodne kwasu 2-fenylopropionowego i zawierające je kompozycje farmaceutyczne |
| EP2166006A1 (en) | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| WO2010078403A2 (en) | 2008-12-30 | 2010-07-08 | Lipella Pharmaceuticals Inc. | Methods and compositions for diagnosing urological disorders |
| US20120076791A1 (en) * | 2010-09-29 | 2012-03-29 | Philip Bosch | Methods Of Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome |
| CN105582134A (zh) * | 2014-09-12 | 2016-05-18 | 青岛华之草医药科技有限公司 | 一种治疗前列腺炎的中药组合物 |
| EP3117835A1 (en) * | 2015-07-14 | 2017-01-18 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment of certain urological disorders |
-
2017
- 2017-01-03 EP EP17150176.0A patent/EP3342407A1/en not_active Withdrawn
-
2018
- 2018-01-02 WO PCT/EP2018/050009 patent/WO2018127469A1/en not_active Ceased
- 2018-01-02 EP EP18701088.9A patent/EP3565545A1/en not_active Withdrawn
- 2018-01-02 MX MX2019007972A patent/MX2019007972A/es unknown
- 2018-01-02 CA CA3046531A patent/CA3046531A1/en not_active Abandoned
- 2018-01-02 MA MA047199A patent/MA47199A/fr unknown
- 2018-01-02 KR KR1020197013259A patent/KR20190102177A/ko not_active Ceased
- 2018-01-02 CN CN201880003982.6A patent/CN109937037A/zh active Pending
- 2018-01-02 BR BR112019009588A patent/BR112019009588A2/pt not_active Application Discontinuation
- 2018-01-02 JP JP2019528129A patent/JP2020503267A/ja not_active Withdrawn
- 2018-01-02 US US16/475,166 patent/US20190336484A1/en not_active Abandoned
- 2018-01-02 EA EA201991357A patent/EA201991357A1/ru unknown
- 2018-01-02 AU AU2018206134A patent/AU2018206134A1/en not_active Abandoned
-
2019
- 2019-04-16 ZA ZA2019/02427A patent/ZA201902427B/en unknown
- 2019-06-23 IL IL267577A patent/IL267577A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018127469A1 (en) | 2018-07-12 |
| IL267577A (en) | 2019-08-29 |
| KR20190102177A (ko) | 2019-09-03 |
| EP3342407A1 (en) | 2018-07-04 |
| MA47199A (fr) | 2019-11-13 |
| JP2020503267A (ja) | 2020-01-30 |
| BR112019009588A2 (pt) | 2019-08-06 |
| EA201991357A1 (ru) | 2019-12-30 |
| CA3046531A1 (en) | 2018-07-12 |
| AU2018206134A1 (en) | 2019-05-23 |
| CN109937037A (zh) | 2019-06-25 |
| EP3565545A1 (en) | 2019-11-13 |
| US20190336484A1 (en) | 2019-11-07 |
| ZA201902427B (en) | 2020-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021552856A1 (en) | Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof | |
| MX2025004367A (es) | Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos | |
| PH12020551760A1 (en) | Pyridazinones as parp7 inhibitors | |
| MX2025006196A (es) | Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso | |
| MX2025003444A (es) | Amidas heterobiciclicas como inhibidoras del cumulo de diferenciacion 38 (cd38) | |
| DOP2018000010A (es) | Inhibidores peptídicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias | |
| EP4019038A3 (en) | Use of c-type natriuretic peptide variants to treat osteoarthritis | |
| MX365294B (es) | Inhibidores de proteína cinasa dependiente de adn. | |
| MX2015011898A (es) | Compuestos de pirazolo y usos de los mismos. | |
| PH12015501221A1 (en) | Pyrimidinones as pi3k inhibitors | |
| MX2021007260A (es) | Inhibidores de la vía de cinasa janus 1 (jak1) para el tratamiento de enfermedades gastrointestinales. | |
| MX2020006365A (es) | Quinazolinonas como inhibidores de poli(adenosin difosfato-ribosa)polimerasa 14 (parp14). | |
| MX2012009748A (es) | USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL. | |
| PH12019502049A1 (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
| SI3324994T1 (sl) | NX-1207 za uporabo v postopkih za zmanjšanje potrebe po operaciji pri pacientih, ki trpijo za benigno hiperplazijo prostate | |
| MX2017005282A (es) | Nuevos compuestos como inhibidores de la cinasa inductora de nf-kb (nik). | |
| PH12015501822A1 (en) | Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines | |
| MX2017005284A (es) | Nuevos derivados de pirazolopirimidina de la cinasa inductora de nf-kb (nk). | |
| MX2020012782A (es) | Inhibidor de ccr5 para el uso en el tratamiento de cancer. | |
| MX2019007972A (es) | Inhibidores de il-8 para usarse en el tratamiento de algunos trastornos urologicos. | |
| PH12021550741A1 (en) | Vibegron for the treatment of overactive bladder symptoms | |
| PL4041128T3 (pl) | Systemy i urządzenia do leczenia łagodnego przerostu gruczołu krokowego i związanych z nim objawów dolnych dróg moczowych | |
| HUE056439T2 (hu) | IL-8 Inhibitorok egyes urológiai rendellenességek kezelése során történõ alkalmazásra | |
| MX387222B (es) | Combinaciones de inhibidores de fgfr4 y secuestrantes de ácido biliar. | |
| MX2019011118A (es) | Uso de oleorresina de copaifera en patologias de la prostata. |